Why the study?
The control of Col I and Col III and the relevance of the Col I/Col III ratio in biological processes significantly impact disease prognosis and progression.
Key points are not available for this paper at this time.
Design
Comprehensive review article
Answers are grounded in this paper and cite their sources.
May guide myocardial stiffness assessment; extends collagen ratio insights but leaves open clinical translation.
The structure of connective tissues including cartilage, tendons, and ligaments as well as many organs, like the skin, heart, liver, kidney, lungs, blood vessels, and bones, depend on collagen. The bulk of the network of structural proteins that make up the extracellular matrix of the heart is composed of collagen type I and type III, which provide structural support for the muscle cells and are crucial for cardiac function. The prognosis and progression of a disease or diseased state may be significantly impacted by the upregulation or downregulation of the collagen types, particularly Col I and Col III. For example, increasing Col I protein levels may impose increasing myocardial stiffness, impairing the diastolic and systolic function of the myocardium. Collagen I is a stiff fibrillar protein that gives tensile strength, whereas Col III produces an elastic network that stores kinetic energy as an elastic rebound. These two collagen proteins have distinct physical properties in nature. Therefore, the control of Col I and Col III as well as the potential relevance of the Col I/Col III ratio in many biological processes serve as the foundation for this comprehensive review article.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2023) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: